Psychiatric Drugs Proven To Cause Suicide


Senior Member

Psychiatric drugs & suicide in Sweden 2007

A report based on data from the
National Board of Health and Welfare
By Janne Larsson

The purpose of this investigation has been to find data about the preceding psychopharmacologic al treatment for all persons who committed suicide in Sweden 2007.

The conclusion is that a large percentage of the persons who committed suicide in Sweden in 2007 had received extensive treatment with psychiatric drugs within a year of and close to the suicide.

This is a report about suicides committed in Sweden (with around 9 million citizens) in 2007 and the psychiatric drug treatment that preceded these suicides.

The report has three main parts:

• It gives unique data about all suicides committed in 2007 and the psychiatric
drugs that the persons received within a year of the suicide.

• It compares these data with autopsy reports about psychiatric drugs found in
the blood (of 98%) of all the persons who committed suicide in 2007.

• It gives extensive information about the psychiatric drug treatment given
within a year to the subgroup of persons who committed suicide in 2007 and
then were reported to the National Board of Health and Welfare by reason of
law 3 - one third of all suicides committed that year.

The data presented on these pages should have been published by the responsible national authorities.

A large percentage of the persons who committed suicide in Sweden in 2007 had received extensive treatment with psychiatric drugs within a year of their suicide.

The idea that persons who are depressed are suffering from “chemical imbalances”nand are deficient in the substance serotonin has been marketed by the pharmaceutical companies selling antidepressants (in the class SSRI, such as Prozac, Paxil/Seroxat, Zoloft) for more than a decade. The intensive marketing has led persons to believe that their low mood is a deficiency disease – and that it is vital to supply the substance that corrects this deficiency – the antidepressant drug.

But there is no scientific evidence that a low mood is caused by a ”chemical imbalance” in the brain 10 11. The hypothesis has been rejected with the following words by one of the most well known names in the field: “The serotonin theory of depression is comparable to the masturbatory theory of insanity.” 12 (The old theory that masturbation caused insanity.)

The Swedish medical agencies and their psychiatric consultants have used old data from forensic toxicological screenings to mislead the public and to heavily increase the use of antidepressants and other psychiatric drugs.

The most important information in this area is the patients’ medical history, the treatment history. Antidepressants, neuroleptics and other psychiatric drugs may cause harmful changes in the brain and these brain dysfunctions do not vanish when the drugs are discontinued – in many cases they cause chronic dysfunction to the brain, exemplified by the known neurological harm caused by neuroleptics. Many patients also get serious withdrawal reactions; reactions that can be so severe that they can lead to suicide.

Better sources of information are the unpublished clinical trials of psychiatric drugs done by pharmaceutical companies, and the important studies done by independent researchers. A number of these studies show that antidepressants and neuroleptics increase the risk of suicidal behaviour and directly cause effects that lead to suicide.

Considering the results presented in this report, it is no longer possible to say that ”more” of the same sort is the solution to the problem. It’s not “more psychiatry” – more psychiatric drugs – that is the solution. Politicians, trying to surpass each other in demanding more funds for a psychiatric industry that only means more “treatment” with psychiatric drugs, should know that they directly contribute to harming people and to the creation of more “results” of the sort presented in this report. Subservient nodding and voting when psychiatric opinion leaders require changes in law, so that people can be drugged with force in their homes, and so that “drug treatment without exceptions” can be given for people with mental problems, only lead to an increase in the psychiatric results described earlier. This report clearly shows one thing: A large majority of persons committed suicide after having had “adequate drug treatment” – in the meaning used in psychiatry; the very treatment that should prevent suicide. There is no reason to believe that the reporting system for adverse drug events work better in other countries. The catastrophic state of these “surveillance systems” makes it possible to keep destructive drugs on the market year after year. All it takes
is for pharmaceutical companies to show that many persons have been exposed to these drugs, and that almost no adverse event reports have been submitted; the drugs must be “safe and effective”.

This example from Sweden shows that in 338 cases persons committed suicide after having been prescribed psychiatric drugs – and none of these cases were reported to the registry for adverse drug events. Instead of Eli Lilly claiming that the drug Zyprexa was involved in 0 cases of suicide in Sweden 2007, the fact was that the drug was involved in 52 cases in this subgroup of 338 persons. Instead of Wyeth claiming the same for Effexor, the fact was that the drug was involved in 41 cases in
this group.

The reporting system must be completely reformed right away. It must be made mandatory for health care professionals to directly report all suspected serious adverse drug effects, and persons not reporting must be disciplined. Patients must be fully informed about the actual harmful effects of the drugs and given the right to report these effects to the adverse events registry, with the promise of effective follow-up. The reformed system must not give room for the now ruling psychiatric concealment ideology, where obvious harmful effects of psychiatric drugs are treated as “symptoms” requiring more drugs. Instead all these effects must be reported as suspected harmful effects from the drugs. And, most importantly, the data presented in this report must lead to basic changes in the ways in which persons with mental problems are being cared for.

Psychiatric drugs & suicide in Sweden 2007
A report based on data from the
National Board of Health and Welfare
By Janne Larsson


Senior Member
More from Janne Larsson
Reporter investigating psychiatry

The ADHD drug Strattera 115 reports of deaths

A new report about deaths in connection with the ADHD drug Strattera shows:

Stockholm, Sweden 5/10/2009 11:41 AM GMT (TransWorldNews)

87 cases of death with Strattera as Primary Suspect Drug reported to the FDA, 2004 - September 2008.

115 cases of death with Strattera involved reported to the FDA 2004 €“ September 2008 and in Periodic Safety Update Reports from Eli Lilly and the UK medical agency MHRA.
for FDA reports.

48 children and teenagers have died, 25 of them committed suicide. See summary

The youngest child reported to have died was only 2 years old €“ had got both Strattera and Zyprexa!

The children getting Strattera can be expected to be healthy normal children and in this group of €œpatients€ there SHOULD BE extremely low morbidity and mortality.

As seen above it is not: 48 children and teenagers who got Strattera €œfor ADHD€ are reported to HAVE DIED. And the number of harmful events reported internationally for the drug is incredible. The last available total figure reported by Eli Lilly to medical authorities in Europe (from May 2006) says that 23,132 spontaneous adverse event reports have been submitted, representing 58,048 adverse events

(And it should be noted that only a fraction of the serious harmful events caused by psychiatric drugs is reported to medical authorities; the ACTUAL number of harmful events and deaths is much higher than what is stated here.)

Parents consulting psychiatrists are told their children are suffering from a €œchemical imbalance€ in the brain and that Strattera (and other ADHD drugs) will correct that. This is a fraudulent statement. Parents who are told that story should ask for a laboratory test. They would then get to know that there is no test available; that the statement about chemical imbalance is just speculation.

As there is nothing medically wrong with these children to begin with (the drugs cannot be prescribed to children with known physical diseases) the harmful effects seen are DRUG INDUCED €“ they are not any form of €œunderlying disease€ showing up. The heart disorders, the liver disorders, the seizure disorders are caused by the drugs. The €œpsychiatric symptoms€ showing up €“ suicidality, aggression, mania and psychosis with hallucinations €“ are toxic effects of the drugs.

The responsible medical authorities (FDA in US, UK MHRA in Europe) have not done an independent investigation of all the cases of death €“ they do not even have a compilation of these. They have so far relied on data and analysis from the manufacturer Eli Lilly, who is only interested in one thing: To explain away all instances of death and increase profits.

The FDA and MHRA have failed to protect children from the harmful effects caused by this drug €“ and they have not even cared to do an investigation of all the reported cases of death.

Janne Larsson
Reporter €“ investigating psychiatry


My comment:
Ritalin, Strattera etc can cause psychosis.
Treatment of psychosis needs an antipsychotic drug.
Zyprexa is Olanzapine in UK - used for schizophrenic adults.
This is deplorable.


Senior Member
Quote " 48 children and teenagers have died, 25 of them committed suicide. See summary

The youngest child reported to have died was only 2 years old had got both Strattera and Zyprexa! "

Zyprexa is number 13 on List of Deadliest Drugs

"A 2007 study conducted by the Institute for Safe Medication Practices and the Division of Public Health Sciences, Wake Forest University School of Medicine found that Zyprexa has one of the highest number of suspect drug deaths, coming in thirteenth on the list of deadly drugs. Furthermore, over the eight years of the study, Zyprexa was linked to 1,005 deaths and 4,110 adverse events. The information was taken from the FDA's Adverse Event Reporting System and was published in the September 10, 2007 issue of Archives of Internal Medicine."

Zyprexa is an atypical antipsychotic, approved to treat schizophrenia and bipolar disorder. Literature about Zyprexa for medical professionals notes that suicide attempts are "inherent to schizophrenia and bipolar disorder." However, as an article [by Evelyn Pringle] notes, "Persons on atypicals have been found to commit suicide two to five times more frequently than the schizophrenic population in general." She further cites author Bob Whitaker, who says that the death rate among people with schizophrenia has doubled since atypical antipsychotics were approved for use.

Some patients, writing on patient blog sites, noted they attempted suicide after as little as two weeks taking Zyprexa. One Zyprexa patient who wrote into LawyersandSettlements said that he has had suicidal thoughts continuously and attempted suicide three times since he started taking Zyprexa.


Senior Member
Woodridge, IL
Why the @#&*# would anyone give a 2 yr old Strattera or Zyprexa, let alone both?

......children that young are never diagnosed with any disorder that would merit such drugs, and even if they were to receive such a diagnosis, it is well known that children do not tolerate psych meds well at all.....there are black box warning for teens, and the thought is that they react more poorly bc their brains are still developing - if teens are still developing what exactly do they think a two yr old is doing?!